Administrative Supplement: Peer Navigators for the ACT NOW OBOE Study

行政补充:ACT NOW OBOE 研究的同行导航员

基本信息

  • 批准号:
    10462326
  • 负责人:
  • 金额:
    $ 57.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-20 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT The opioid epidemic does not differentiate based on gender or life experience, with impacts on a range of individuals, including women who are pregnant. Infants born to mothers who use opioids during pregnancy are at risk for neonatal opioid withdrawal syndrome (NOWS). However, mothers with opioid use disorder (OUD) often face many challenges in seeking health care and treatment, including concerns about stigma, prosecution, and loss of their infant. The ACT NOW Outcomes of Babies with Opioid Exposure (OBOE) Study is a multisite longitudinal cohort study of infants with antenatal opioid exposure and control infants designed to (1) determine the impact of antenatal opioid exposure on brain structure and connectivity over the first 2 years of life; (2) define medical, developmental, and behavioral outcomes over the first 2 years of life in infants exposed to opioids; and (3) explore whether and how the home environment, maternal mental health, and parenting modify trajectories of brain connectivity and neurodevelopment over the first 2 years of life. The ACT NOW OBOE Study has the potential to significantly advance understanding of outcomes among infants with antenatal opioid exposure through this groundbreaking neuroimaging study. The study investigators propose the addition of peer navigators to ensure a diverse and inclusive study population and thereby improve the generalizability of study findings. Common challenges encountered in recruiting study participants from underrepresented populations have included distrust in science, concerns about safety of MRIs, placements of infants in foster care, and practical and logistical challenges for the mother and family, including food insecurity, transportation concerns, and lack of childcare for other children. The specific aim of this administrative supplement is to provide data management and logistical coordination to support an increase in capitation funds to address challenges in study recruitment and retention through the inclusion of peer navigators in the ACT NOW OBOE Study. In addition to assisting with study recruitment and retention, peer navigators will provide much needed support and resources to mothers with OUD and connect them to available services, including food programs, and psychosocial or material supports such as counseling, peer recovery support, and community linkages to care.
项目总结/摘要 阿片类药物的流行并不因性别或生活经历而有所区别,对一系列的人产生了影响。 个人,包括怀孕的妇女。怀孕期间使用类阿片的母亲所生的婴儿 新生儿阿片类药物戒断综合征(NOWS)的风险。然而,患有阿片类药物使用障碍的母亲 (OUD)在寻求医疗保健和治疗方面往往面临许多挑战,包括对污名化的担忧, 起诉,和失去他们的婴儿。阿片类药物暴露婴儿的立即行动结果(OBOE) 研究是一项对产前阿片类药物暴露婴儿和对照婴儿进行的多中心纵向队列研究 旨在(1)确定产前阿片类药物暴露对大脑结构和连接的影响, 生命的前2年;(2)定义前2年的医疗、发育和行为结果 生活中的婴儿暴露于阿片类药物;(3)探讨是否以及如何家庭环境,产妇 心理健康和育儿首先会改变大脑连接和神经发育的轨迹 两年的生活。ACT NOW OBOE研究有可能大大促进对以下问题的理解: 通过这项开创性的神经成像研究,对产前暴露于阿片类药物的婴儿进行了研究。 研究人员建议增加同行导航员,以确保研究的多样性和包容性 人口,从而提高研究结果的普遍性。共同面临的挑战 从代表性不足的人群中招募研究参与者包括对科学的不信任, 关于核磁共振成像的安全性,寄养婴儿的安置,以及 母亲和家庭的问题,包括粮食不安全、交通问题和其他儿童缺乏托儿服务。 这一行政补充的具体目的是提供数据管理和后勤协调 支持增加人头费,以应对研究招募和保留方面的挑战, 在ACT NOW OBOE研究中纳入同行导航员。除了协助研究招募外 和保留,同伴导航员将提供急需的支持和资源,以母亲与OUD, 将他们与可用的服务联系起来,包括食品计划,以及心理社会或物质支持, 咨询、同伴康复支持和社区与护理的联系。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Psychometric Properties of the Prenatal Opioid Use Perceived Stigma Scale and Its Use in Prenatal Care.
产前阿片类药物使用感知耻辱量表的心理测量特性及其在产前护理中的应用。
  • DOI:
    10.1016/j.jogn.2022.12.002
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bann,CarlaM;Newman,JamieE;Okoniewski,KatherineC;Clarke,Leslie;Wilson-Costello,Deanne;Merhar,Stephanie;Mack,Nicole;DeMauro,Sara;Lorch,Scott;Ambalavanan,Namasivayam;Limperopoulos,Catherine;Poindexter,Brenda;Walsh,Michele;Davis,
  • 通讯作者:
    Davis,
Risk factors for food insecurity and association with prenatal care utilization among women who took opioids during pregnancy.
怀孕期间服用阿片类药物的妇女的粮食不安全风险因素及其与产前保健利用的关系。
  • DOI:
    10.21203/rs.3.rs-3921909/v1
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Parlberg,LindsayM;Newman,JamieE;Merhar,Stephanie;Poindexter,Brenda;DeMauro,Sara;Lorch,Scott;Peralta-Carcelen,Myriam;Wilson-Costello,Deanne;Ambalavanan,Namasivayam;Limperopoulos,Catherine;Mack,Nicole;Davis,JonathanM;Walsh,Michel
  • 通讯作者:
    Walsh,Michel
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CARLA M BANN其他文献

CARLA M BANN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CARLA M BANN', 18)}}的其他基金

The Darbepoetin Kindergarten Development Study
达贝泊汀幼儿园发展研究
  • 批准号:
    10734625
  • 财政年份:
    2023
  • 资助金额:
    $ 57.5万
  • 项目类别:
HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium
HEAL 计划:产前阿片类药物暴露纵向研究联盟
  • 批准号:
    10414223
  • 财政年份:
    2019
  • 资助金额:
    $ 57.5万
  • 项目类别:
HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium
HEAL 计划:产前阿片类药物暴露纵向研究联盟
  • 批准号:
    9901874
  • 财政年份:
    2019
  • 资助金额:
    $ 57.5万
  • 项目类别:
Administrative Supplement to Increase Participant Diversity, Inclusion and Engagement in the ACT NOW OBOE Study
增加 ACT NOW OBOE 研究参与者多样性、包容性和参与度的行政补充
  • 批准号:
    10400379
  • 财政年份:
    2019
  • 资助金额:
    $ 57.5万
  • 项目类别:
Research Support Core - Outcomes of Babies with Opioid Exposure (OBOE)
研究支持核心 - 接触阿片类药物的婴儿 (OBOE) 的结果
  • 批准号:
    9901876
  • 财政年份:
  • 资助金额:
    $ 57.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了